Orthobiologics Market PPT 2022: Size, Growth, Demand and Forecast till 2027

Author: Elena Anderson

Marketing Manager

Report DescriptionAbout IMARC Group

International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all regions and industry verticals to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

Global Orthobiologics Market Research Report 2022-2027:

According to the latest report by IMARC Group, titled "Orthobiologics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

," the global orthobiologics market size reached US$ 5.4 Billion in 2021.

Orthobiologics are prescription drugs made by living organisms to heal orthopedic tissues. Some of the common orthobiologics include bone marrow concentrate, platelet-rich plasma (PRP), birth tissues and certain fat grafts. These are autologous or allogeneic substances that are injected or placed surgically toacceleratethe healing of bones, joints, muscles, or tendons.Nowadays, plateletrich plasma (PRP) is a rapidly gaining tractionin the field of regenerative medicine, showing excellent potential in triggering or expediting the healing process in bones, muscles and ligaments.

Request for a PDF sample of this report:

https://www.imarcgroup.com/orthobiologics-market/requestsample

Global Orthobiologics Market Trends:

The market is primarily driven by the increasing prevalence of osteoarthritis(OA), especially among the geriatric population. Older adultsare also highly susceptible to spinal and other orthopedic disorders, resulting in the need foran increased number of orthopedic procedures. Besides this, the rising awareness among physicians and patients aboutthe benefits oforthobiologic therapies and newly introduced treatment procedures and technologies have encouraged them to opt for orthobiologics.

Moreover, extensive investments and collaborations by prominent medical device and biotechnology companies in the research and development (R&D) to produce advanced orthobiologics are providing a positive market outlook. Some of the other factors, including the growing preference for minimally invasive (MI) procedures, improving healthcare infrastructure and advent of next-generation biologics technology, are also contributing to the market growth.

Looking forward, the market is anticipated to grow at a CAGR of 5.27% during the forecast period (2022-2027).

View Report TOC, Figures and Tables: https://www.imarcgroup.com/orthobiologics-market

Report Description Report Description and Highlights

Key Market Segmentation

The research report includes the following segments:

Breakup by Product:

• Demineralized Bone Matrix

• Allograft

• Bone Morphogenetic Protein

• Viscosupplementation Products

• Synthetic Bone Substitutes

• Others

Breakup by Type:

• Knee

• Ankle

• Hip

• Wrist and Shoulder

• Spine

• Others

Report Description Report Description and Highlights

Breakup by Application:

• Osteoarthritis and Degenerative Arthritis

• Spinal Fusion

• Fracture Recovery

• Soft Tissue Injuries

• Maxillofacial and Dental Applications

Breakup by End User:

• Hospitals and Ambulatory Centers

• Research and Academic Institutes

• Dental Clinics and Facilities

• Orthopedic Clinics

Breakup by Region:

• North America

• Asia Pacific

• Europe

• Latin America

• Middle East and Africa

Competitive Landscape with Key Players:

• Arthrex Inc

• Globus Medical Inc

• Integra LifeSciences

• Johnson & Johnson

• Medline Industries Inc

• Medtronic plc

• NuVasive Inc

• Orthofix Medical Inc

• Smith & Nephew plc

• Stryker Corporation

• Terumo Corporation

• Wright Medical Group N.V

• Zimmer Biomet

1. How has the global orthobiologics market performed so far and how will it perform in the coming years?

2. What has been the impact of COVID-19 on the global orthobiologics market?

3. What are the key regional markets?

4. What is the breakup of the market based on the product?

5. What is the breakup of the market based on the type?

6. What is the breakup of the market based on the application?

7. What is the breakup of the market based on the end user?

8. What are the various stages in the value chain of the industry?

9. What are the key driving factors and challenges in the industry?

10. What is the structure of the global orthobiologics market and who are the key players?

11. What is the degree of competition in the industry?

Click here to visit the complete table of content with list of figures and tables: https://www.imarcgroup.com/orthobiologics-market/toc

A partial List of our Clients

Partial List of Clients

We are the trusted business partners to the world's leading corporates, governments, and institutions

A partial List of our Clients

Partial List of Clients

We are the trusted business partners to the world's leading corporates, governments, and institutions

Report Description Report Description and Highlights

© 2022 IMARC All Rights Reserved

This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC).

Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication.

IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.